EP3534913A4 - Zusammensetzung und verfahren zur behandlung von otitis - Google Patents

Zusammensetzung und verfahren zur behandlung von otitis Download PDF

Info

Publication number
EP3534913A4
EP3534913A4 EP17868280.3A EP17868280A EP3534913A4 EP 3534913 A4 EP3534913 A4 EP 3534913A4 EP 17868280 A EP17868280 A EP 17868280A EP 3534913 A4 EP3534913 A4 EP 3534913A4
Authority
EP
European Patent Office
Prior art keywords
composition
treating otitis
otitis
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP17868280.3A
Other languages
English (en)
French (fr)
Other versions
EP3534913A1 (de
Inventor
Joseph CAPRIOTTI
Kara CAPRIOTTI
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Veloce Biopharma LLC
Original Assignee
Veloce Biopharma LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US15/341,930 external-priority patent/US20170071979A1/en
Application filed by Veloce Biopharma LLC filed Critical Veloce Biopharma LLC
Publication of EP3534913A1 publication Critical patent/EP3534913A1/de
Publication of EP3534913A4 publication Critical patent/EP3534913A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/04—Amoebicides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/18—Iodine; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0046—Ear
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
EP17868280.3A 2016-11-02 2017-11-01 Zusammensetzung und verfahren zur behandlung von otitis Withdrawn EP3534913A4 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15/341,930 US20170071979A1 (en) 2011-05-11 2016-11-02 Composition and method for treating otitis
PCT/US2017/059513 WO2018085384A1 (en) 2016-11-02 2017-11-01 Composition and method for treating otitis

Publications (2)

Publication Number Publication Date
EP3534913A1 EP3534913A1 (de) 2019-09-11
EP3534913A4 true EP3534913A4 (de) 2020-07-15

Family

ID=60860035

Family Applications (1)

Application Number Title Priority Date Filing Date
EP17868280.3A Withdrawn EP3534913A4 (de) 2016-11-02 2017-11-01 Zusammensetzung und verfahren zur behandlung von otitis

Country Status (5)

Country Link
EP (1) EP3534913A4 (de)
JP (3) JP6255134B1 (de)
KR (3) KR20190100442A (de)
CN (1) CN108472313A (de)
WO (1) WO2018085384A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021198940A1 (ja) * 2020-03-31 2021-10-07 タイ ミン ファーマシューティカルズ ジェイエスシー ヒト又は動物の慢性若しくは急性のウイルス感染症及び／又は敗血症の予防若しくは治療のための組成物
JP2021161105A (ja) * 2020-03-31 2021-10-11 タイ ミン ファーマシューティカルズ ジェイエスシー ヒト又は動物の慢性若しくは急性のウイルス感染症及び／又は敗血症の予防若しくは治療のための組成物
FR3122572A1 (fr) * 2021-05-07 2022-11-11 Nadine GRISLAIN Composition pharmaceutique bioadhésive comprenant du PVPI

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060280809A1 (en) * 2005-06-14 2006-12-14 Leshchiner Adele K Anti-infective iodine based compositions for otic and nasal use
WO2013040347A1 (en) * 2011-09-16 2013-03-21 Foresight Biotherapeutics, Inc. Stable povidone-iodine compositions
WO2016118424A1 (en) * 2015-01-20 2016-07-28 Veloce Biopharma Llc Novel iodophor composition and methods of use

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4241051A (en) * 1977-11-04 1980-12-23 Christie Robert B Calcitonin
CN101137359B (zh) * 2005-03-10 2011-01-12 3M创新有限公司 治疗耳感染的方法
DE202005004183U1 (de) * 2005-03-14 2005-05-25 G. Pohl-Boskamp Gmbh & Co. Kg Ohrentropfen zum Einbringen in den Gehörgang
CN101002775A (zh) * 2006-01-18 2007-07-25 广州白云山制药股份有限公司广州白云山制药总厂 一种抗感染制剂
GB0709513D0 (en) * 2007-05-17 2007-06-27 Helperby Therapeutics Ltd Topical formulations
US20090263345A1 (en) * 2008-01-28 2009-10-22 Foresight Biotherapeutics, Inc. Otic compositions for the treatment of infections of the internal and external ear in mammals
US20100016450A1 (en) * 2008-07-21 2010-01-21 Otonomy, Inc. Controlled release delivery devices for the treatment of otic disorders
TWI618539B (zh) * 2009-12-15 2018-03-21 遠景生物製藥股份有限公司 無刺激性眼用聚乙烯吡咯啶酮-碘組成物
CA2786525A1 (en) * 2010-01-07 2011-07-14 Regents Of The University Of Minnesota Methods and compositions for applying moxifloxacin to the ear
ES2391721T3 (es) * 2010-03-01 2012-11-29 Laboratorios Salvat, S.A. Disoluciones acuosas transparentes de acetónido de fluocinolona para el tratamiento de la infamación de oído
EP2707007B1 (de) * 2011-05-11 2018-03-07 Veloce BioPharma LLC Fungizide zusammensetzungen zur behandlung von nägeln
US20140271529A1 (en) * 2013-03-14 2014-09-18 Alc Therapeutics, Llc Antifungal compositions for the treatment of secondary skin and nail infections
US9539223B2 (en) * 2013-05-01 2017-01-10 Neoculi Pty Ltd Methods for treating bacterial infections

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060280809A1 (en) * 2005-06-14 2006-12-14 Leshchiner Adele K Anti-infective iodine based compositions for otic and nasal use
WO2013040347A1 (en) * 2011-09-16 2013-03-21 Foresight Biotherapeutics, Inc. Stable povidone-iodine compositions
WO2016118424A1 (en) * 2015-01-20 2016-07-28 Veloce Biopharma Llc Novel iodophor composition and methods of use

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
LINDA K WONG ET AL: "Volume 46 | Issue 2 Clinical Considerations of Dimethyl Sulfoxide Recommended Citation Clinical Considerations of Dimethyl Sulfoxide", 1 January 1984 (1984-01-01), XP055700607, Retrieved from the Internet <URL:https://lib.dr.iastate.edu/cgi/viewcontent.cgi?referer=https://www.google.com/&httpsredir=1&article=3126&context=iowastate_veterinarian> [retrieved on 20200603] *
ROSYCHUK R A W: "MANAGEMENT OF OTITIS EXTERNA", VETERINARY CLINICS OF NORTH AMERICA: SMALL ANIMAL PRACTICE, SAUNDERS, PHILADELPHIA, US, vol. 24, no. 5, 1 September 1994 (1994-09-01), pages 921 - 953, XP000670927, ISSN: 0195-5616 *
See also references of WO2018085384A1 *

Also Published As

Publication number Publication date
JP6255134B1 (ja) 2017-12-27
KR20180059554A (ko) 2018-06-04
JP2018070583A (ja) 2018-05-10
JP2018070620A (ja) 2018-05-10
EP3534913A1 (de) 2019-09-11
JP2018070655A (ja) 2018-05-10
KR20180061359A (ko) 2018-06-07
CN108472313A (zh) 2018-08-31
WO2018085384A1 (en) 2018-05-11
JP6271804B1 (ja) 2018-01-31
KR20190100442A (ko) 2019-08-28

Similar Documents

Publication Publication Date Title
EP3555077A4 (de) Zusammensetzungen und verfahren zur behandlung von krebs
EP3247359A4 (de) Zusammensetzungen und verfahren zur behandlung von krampfanfällen
EP3532464A4 (de) Zusammensetzungen und verfahren zur behandlung von ezh2-vermitteltem krebs
EP3490582A4 (de) Verfahren und zusammensetzungen zur behandlung von myelofibrose
EP3681525A4 (de) Zusammensetzung und verfahren zur behandlung von autismus
EP3193862A4 (de) Cannabinoidverbindung und verfahren zur behandlung von schmerzen
EP3277270A4 (de) Zusammensetzungen und verfahren zur behandlung von anämie
EP3704227A4 (de) Zusammensetzung und verfahren
EP3462883A4 (de) Zusammensetzungen und verfahren zur behandlung von krebs
EP3261644A4 (de) Zusammensetzungen und verfahren zur behandlung von netzhautdegeneration
EP3458079A4 (de) Zusammensetzungen und verfahren zur behandlung von akne
EP3359663A4 (de) Zusammensetzung und verfahren zur behandlung einer komplementvermittelten erkrankung
EP3528798A4 (de) Zusammensetzungen und verfahren zur behandlung von krebs
EP3402575A4 (de) Verfahren und zusammensetzungen zur behandlung von geschädigtem haar
EP3541421A4 (de) Zusammensetzungen und verfahren zur behandlung von krebs
EP3471746A4 (de) Verfahren und zusammensetzung zur behandlung von krampfanfällen
EP3405172A4 (de) Verfahren und zusammensetzungen zur behandlung von gealterter haut
EP3405191A4 (de) Verfahren und zusammensetzungen zur behandlung von hyperhidrose
EP3468546A4 (de) Zusammensetzungen und verfahren zur behandlung von krebs
EP3352729A4 (de) Verfahren und zusammensetzungen zur hautbehandlung
EP3429613A4 (de) Zusammensetzungen und verfahren zur behandlung von krebs
EP3262065A4 (de) Verfahren und zusammensetzungen zur behandlung von dystroglycanopathieerkrankungen
EP3273951A4 (de) Zusammensetzungen und verfahren zur behandlung von schuppenflechte
HK1243635A1 (zh) 治療皮膚病況的組合物和方法
EP3411367A4 (de) Zusammensetzungen und verfahren zur behandlung von infektionen

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20190531

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20200616

RIC1 Information provided on ipc code assigned before grant

Ipc: A61P 31/04 20060101ALI20200609BHEP

Ipc: A61P 27/16 20060101ALI20200609BHEP

Ipc: A61P 31/10 20060101ALI20200609BHEP

Ipc: A61K 47/58 20170101ALI20200609BHEP

Ipc: A61P 33/04 20060101ALI20200609BHEP

Ipc: A61K 47/38 20060101ALI20200609BHEP

Ipc: A61K 9/06 20060101ALI20200609BHEP

Ipc: A61K 9/00 20060101ALI20200609BHEP

Ipc: A61K 47/06 20060101ALI20200609BHEP

Ipc: A61P 31/12 20060101ALI20200609BHEP

Ipc: A61P 31/02 20060101ALI20200609BHEP

Ipc: A61K 47/32 20060101ALI20200609BHEP

Ipc: A61K 33/18 20060101AFI20200609BHEP

Ipc: A61K 47/10 20170101ALI20200609BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20220601